Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...

A study led by two undergraduate students at the University of Galway found that GLP-1 receptor agonists, a type of diabetes ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

Retatrutide targets GIP and GLP-1 – the same as Lilly’s fast-growing diabetes ... ADA, Pfizer revealed that it had decided to end the development of one of its once-daily oral GLP-1 agonist ...

The American Diabetes Association has recognized Bonner General Health through the organization's Education Recognition Program. The diabetes self-management education and support service was ...

The company is now running phase 3 trials of the drug in both diabetic (ACHIEVE ... Ingelheim and Zealand Pharma was also presented at ADA. 46 weeks of treatment with their dual glucagon/GLP1 ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

According to the American Diabetes Association (ADA), almost 1 in 3 people in America ... are a class of prescription drugs. They’re used to treat a variety of conditions such as glaucoma ...